NeoSITE Cervical FISH Assay by NeoGenomics Enhances Cervical Cancer Diagnostics for Abnormal Pap Tests
News
NeoGenomics recently announced it has begun to expand its extensive FISH (Fluorescence In Situ Hybridization) range of services by also offering a novel NeoSITE Cervical assay to improve diagnostic patient data obtained ... Read more